Griffey Richard Thomas, Schneider Ryan M, Sharp Brian R, Pothof Jeffrey J, Hodkins Sheridan, Capp Roberta, Wiler Jennifer L, Sreshta Neil, Sather John E, Sampson Christopher S, Powell Jonathan T, Groner Kathryn Y, Adler Lee M
From the Division of Emergency Medicine, Washington University in St. Louis, St. Louis, Missouri.
Department of Emergency Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
J Patient Saf. 2020 Dec;16(4):e245-e249. doi: 10.1097/PTS.0000000000000379.
Quality and safety review for performance improvement is important for systems of care and is required for US academic emergency departments (EDs). Assessment of the impact of patient safety initiatives in the context of increasing burdens of quality measurement compels standardized, meaningful, high-yield approaches for performance review. Limited data describe how quality and safety reviews are currently conducted and how well they perform in detecting patient harm and areas for improvement. We hypothesized that decades-old approaches used in many academic EDs are inefficient and low yield for identifying patient harm.
We conducted a prospective observational study to evaluate the efficiency and yield of current quality review processes at five academic EDs for a 12-month period. Sites provided descriptions of their current practice and collected summary data on the number and severity of events identified in their reviews and the referral sources that led to their capture. Categories of common referral sources were established at the beginning of the study. Sites used the Institute for Healthcare Improvement's definition in defining an adverse event and a modified National Coordinating Council for Medication Error Reporting and Prevention (MERP) Index for grading severity of events.
Participating sites had similar processes for quality review, including a two-level review process, monthly reviews and conferences, similar screening criteria, and a grading system for evaluating cases. In 60 months of data collection, we reviewed a total of 4735 cases and identified 381 events. This included 287 near-misses, errors/events (MERP A-I) and 94 adverse events (AEs) (MERP E-I). The overall AE rate (event rate with harm) was 1.99 (95% confidence interval = 1.62%-2.43%), ranging from 1.24% to 3.47% across sites. The overall rate of quality concerns (events without harm) was 6.06% (5.42%-6.78%), ranging from 2.96% to 10.95% across sites. Seventy-two-hour returns were the most frequent referral source used, accounting for 47% of the cases reviewed but with a yield of only 0.81% in identifying harm. Other referral sources similarly had very low yields. External referrals were the highest yield referral source, with 14.34% (10.64%-19.03%) identifying AEs. As a percentage of the 94 AEs identified, external referrals also accounted for 41.49% of cases.
With an overall adverse event rate of 1.99%, commonly used referral sources seem to be low yield and inefficient for detecting patient harm. Approximately 6% of the cases identified by these criteria yielded a near miss or quality concern. New approaches to quality and safety review in the ED are needed to optimize their yield and efficiency for identifying harm and areas for improvement.
为改进医疗服务而进行的质量与安全审查对医疗系统至关重要,是美国学术性急诊科所必需的。在质量测量负担日益加重的背景下,评估患者安全举措的影响促使采用标准化、有意义且高效的绩效审查方法。有限的数据描述了目前质量与安全审查是如何进行的,以及它们在检测患者伤害和改进领域方面的表现如何。我们假设许多学术性急诊科使用了数十年的方法在识别患者伤害方面效率低下且产出不高。
我们进行了一项前瞻性观察性研究,以评估五个学术性急诊科在12个月期间当前质量审查流程的效率和产出。各研究点提供了其当前做法的描述,并收集了关于审查中发现的事件数量和严重程度以及导致事件被发现的转诊来源的汇总数据。在研究开始时确定了常见转诊来源的类别。各研究点采用医疗改进研究所的定义来界定不良事件,并采用修改后的国家用药错误报告和预防协调委员会(MERP)指数对事件严重程度进行分级。
参与研究的各点在质量审查方面有相似的流程,包括两级审查流程、月度审查和会议、相似的筛查标准以及用于评估病例的分级系统。在60个月的数据收集过程中,我们总共审查了4735个病例,识别出381起事件。这包括287起险些发生的错误、差错/事件(MERP A - I级)和94起不良事件(AEs)(MERP E - I级)。总体不良事件发生率(造成伤害的事件发生率)为1.99%(95%置信区间 = 1.62% - 2.43%),各研究点的发生率在1.24%至3.47%之间。总体质量问题发生率(未造成伤害的事件发生率)为6.06%(5.42% - 6.78%),各研究点的发生率在2.96%至10.95%之间。72小时回访是最常使用的转诊来源,占审查病例的47%,但在识别伤害方面的产出仅为0.81%。其他转诊来源的产出同样很低。外部转诊是产出率最高的转诊来源,有14.34%(10.64% - 19.03%)识别出不良事件。作为所识别出的94起不良事件的百分比,外部转诊也占病例的41.49%。
总体不良事件发生率为1.99%,常用的转诊来源在检测患者伤害方面似乎产出低且效率低。通过这些标准识别出的病例中,约6%产生了险些发生的错误或质量问题。需要采用新的急诊科质量与安全审查方法,以优化其在识别伤害和改进领域方面的产出和效率。